MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0027308
Dasha Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.54 Cr
▲ 25% YoY
Net profit · FY 2025
₹26.68 Lakh
Net margin 5.9%
EBITDA · FY 2025
₹49.68 Lakh
EBITDA margin 10.9%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹11.12 Cr
Issued & subscribed
Open charges
₹31.58 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
5
As per MCA filings
About Dasha Pharmaceuticals Private Limited
Data last updated:
Dasha Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 29 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2020PTC140212. Its GSTIN is 36AAHCD7326A1ZY (Telangana).
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹11.12 Cr. It is led by directors including Shankar Cheepirishetti (Managing Director) and Donald Charles Ross.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Villa 13 Sri Krishnasai Meadows Nizampet, Hyderabad, Telangana, India – 500090.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.54 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹26.68 Lakh (net margin 5.9%) and EBITDA of ₹49.68 Lakh (EBITDA margin 10.9%). Revenue has grown at a compounded annual rate (CAGR) of 358% over three years.
As per MCA filings, the company has open charges of ₹31.58 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Dasha Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0027308). For more details, the company can be reached via its website dashapharma.com.
Company details
CIN U24290TG2020PTC140212
Registration Number 140212
Incorporation Date 29 April 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0027308
Key People
Shankar Cheepirishetti Managing Director Donald Charles Ross Director Arunalatha Cheepirishetti Director Recognitions & Rankings of Dasha Pharmaceuticals
Contact details
Dasha Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is dashapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVilla 13 Sri Krishnasai Meadows Nizampet, Hyderabad, Telangana, India – 500090
- IndustryPharma, API Manufacturers
To see the full contact details of Dasha Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Dasha Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dasha Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dasha Pharmaceuticals Private Limited, buy the company report.
Financials of Dasha Pharmaceuticals Private Limited
FY 2025 filings availableDasha Pharmaceuticals Private Limited reported revenue of ₹4.54 Cr (up 25% YoY) for FY 2025.
Revenue · FY 2025
₹4.54 Cr ▲ 25%
Net profit · FY 2025
₹26.68 Lakh margin 5.9%
EBITDA · FY 2025
₹49.68 Lakh margin 10.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 358%
EBITDA CAGR growth
1 year
▼ 21%
3 years · compounded
▲ 51%
Revenue has grown at a compounded annual rate (CAGR) of 358% over three years, including 25% growth in the latest year. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹49.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.9% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dasha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dasha Pharmaceuticals Private Limited
Dasha Pharmaceuticals has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Donald Charles Ross Also directs: Dasha Science Park Private Limited | Director | 29 Apr 2020 | 6 Years 6 Months | Current |
| Shankar Cheepirishetti Also directs: Dasha Life Sciences LLP, Dasha Science Park Private Limited | Managing Director | 29 Apr 2020 | 6 Years 6 Months | Current |
| Arunalatha Cheepirishetti Also directs: Dasha Life Sciences LLP, Dasha Science Park Private Limited | Director | 29 Apr 2020 | 6 Years 6 Months | Current |
| Ashrit Cheepirishetti Also directs: Dasha Science Park Private Limited | Director | 29 Apr 2020 | 6 Years 6 Months | Current |
| Snehitha Komarraj | Director | 13 Oct 2022 | 4 Years 0 Months | Current |
Peer comparison
Dasha Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Elamus Pharmaceuticals Private Limited | ₹4.58 Cr (FY 2025) | 57.0% | Jogeshwari West, Maharashtra, India | |||
| Chennai Oscar Bio Pharmaceuticals Private Limited | ₹4.55 Cr (FY 2024) | -8.0% | Chennai, Tamil Nadu, India | |||
| Dasha Pharmaceuticals Private Limitedthis company | ₹4.54 Cr (FY 2025) | ₹26.68 Lakh | 5.9% | 25.0% | Hyderabad, Telangana, India | |
| Moradiya Chemicals Private Limited | ₹4.52 Cr (FY 2025) | 36.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Dasha Pharmaceuticals Private Limited, buy the company report.
Auditor
Dasha Pharmaceuticals Private Limited is audited by R K S B & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R K S B & ASSOCIATES | FY 2023 | 016795S |
Shareholding
The shareholding of Dasha Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Dasha Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹31.58 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Mar 2024 | 100887201 | Others | ₹31.58 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Dasha Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Dasha Pharmaceuticals. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medak, Telangana | Civil suit | Filed by the company against an individual | Pending |
To see the full case history of Dasha Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dasha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dasha Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCD7326A1ZY | Telangana | Active | 09 Nov 2020 |
To see the full GST registrations and return filing status of Dasha Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dasha Pharmaceuticals Private Limited has 5 board changes on record since 2020: 5 appointments. The latest: Snehitha Komarraj was appointed as Director on 13 Oct 2022.
AGM
Dasha Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dasha Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 31.58 Cr with Charge ID 100887201 was registered on 21 Mar 2024.
Appointed
Snehitha Komarraj was appointed as Director.
Appointed
Arunalatha Cheepirishetti was appointed as Director.
Appointed
Ashrit Cheepirishetti was appointed as Director.
Appointed
Donald Charles Ross was appointed as Director.
Appointed
Shankar Cheepirishetti was appointed as Managing Director.
Incorporation
29 Apr 2020
Dasha Pharmaceuticals Private Limited was registered on 29 Apr 2020 with Roc Hyderabad & aged 6 years 6 months as per MCA records.
Frequently asked questions
Dasha Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 29 April 2020 (6+ years old) and is registered under CIN U24290TG2020PTC140212.
Dasha Pharmaceuticals has 5 current directors:
- Shankar Cheepirishetti - Managing Director
- Donald Charles Ross - Director
- Arunalatha Cheepirishetti - Director
- Ashrit Cheepirishetti - Director
- Snehitha Komarraj - Director
The latest financial statements of Dasha Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Dasha Pharmaceuticals is 36AAHCD7326A1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Dasha Pharmaceuticals is U24290TG2020PTC140212. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dasha Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
Dasha Pharmaceuticals was incorporated on 29 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Dasha Pharmaceuticals by revenue are Elamus Pharmaceuticals Private Limited, Chennai Oscar Bio Pharmaceuticals Private Limited, Moradiya Chemicals Private Limited, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Snehitha Komarraj was appointed as Director on 13 Oct 2022. Arunalatha Cheepirishetti was appointed as Director on 29 Apr 2020. Ashrit Cheepirishetti was appointed as Director on 29 Apr 2020. Dasha Pharmaceuticals has 5 board changes on record in total.
Yes, Dasha Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0027308).
Dasha Pharmaceuticals can be reached through the website dashapharma.com. Its registered office is in Hyderabad, Telangana, India.